F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices

Estimated reading time: 1 minutes

• About The Author

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive insulin products and forced patients to pay more.

About The Author

See author's posts

Trending

Android malware steals payment card data using previously unseen technique